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http://www.biomedcentral.com/1471-244X/12/87RESEARCH ARTICLE Open AccessThe effect of clinician-patient alliance and
communication on treatment adherence in
mental health care: a systematic review
Laura Thompson* and Rose McCabeAbstract
Background: Nonadherence to mental health treatment incurs clinical and economic burdens. The clinician-patient
alliance, negotiated through clinical interaction, presents a critical intervention point. Recent medical reviews of
communication and adherence behaviour exclude studies with psychiatric samples. The following examines the
impact of clinician-patient alliance and communication on adherence in mental health, identifying the specific
mechanisms that mobilise patient engagement.
Methods: In December 2010, a systematic search was conducted in Pubmed, PsychInfo, Web of Science, Cochrane
Library, Embase and Cinahl and yielded 6672 titles. A secondary hand search was performed in relevant journals,
grey literature and reference.
Results: 23 studies met the inclusion criteria for the review. The methodological quality overall was moderate.
17 studies reported positive associations with adherence, only four of which employed intervention designs.
10 studies examined the association between clinician-patient alliance and adherence. Subjective ratings of clinical
communication styles and messages were assessed in 12 studies. 1 study examined the association between
objectively rated communication and adherence. Meta-analysis was not possible due to heterogeneity of methods.
Findings were presented as a narrative synthesis.
Conclusions: Clinician-patient alliance and communication are associated with more favourable patient adherence.
Further research of observer rated communication would better facilitate the application of findings in clinical
practice. Establishing agreement on the tasks of treatment, utilising collaborative styles of communication and
discussion of treatment specifics may be important for clinicians in promoting cooperation with regimens. These
findings align with those in health communication. However, the benefits of shared decision making for adherence
in mental health are less conclusive than in general medicine.
Keywords: Communication, Alliance, Adherence, Mental healthBackground
Clinical practice in mental health has transformed in re-
cent decades, principally fuelled by pharmacological
advances. Consequently, the composition and objectives
of psychiatric encounters have changed and in turn the
roles of clinicians. The development of atypical antipsy-
chotics and successful use of Selective Serotonin Reuptake
Inhibitors render psychopharmacology an increasingly* Correspondence: l.b.thompson@qmul.ac.uk
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distribution, and reproduction in any mediumprimary task [1]: A central function of consultations is
medication management via regular review and regime
modification [2]. This shift in role definition raises ques-
tions about the purpose and nature of the clinician-
patient relationship and its influence on salient outcomes
of the process of care including adherence to prescribed
treatment e.g. what must a clinician say and do to op-
timise patient engagement? Adherence is defined as
the extent to which the patient’s behaviour coincides
with medical or health advice [3] and constitutes a cru-
cial intermediate outcome for most mental disorders.ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and economic burdens including relapse, rehospitalisa-
tion and poor prognosis. Determinants of adherence
span several factors relating to demographics, illness,
attitudes towards treatment and psychosocial issues [4].
Side effects also present a consistent and understandable
challenge for patients. Discontinuation of assigned treat-
ment may owe to inefficacy or intolerable effects of
medication [5]. In terms of a potential point of interven-
tion, it is important to fully understand the role of the
clinician-patient relationship, or ‘alliance’ as it will be re-
ferred to hereafter. ‘Compliance therapies’ have been
trialled by clinicians, based on cognitive behavioural
techniques. Trained clinicians deliver specific thera-
peutic interventions that topicalise medication cessation
and relapse, normalising rationales for stigma and recog-
nition of characteristic prodromal symptoms [6]. These
appear to retain benefits in the short term [7]. However,
standard psychiatric encounters involve non-specific
counselling to stimulate positive attitudes towards treat-
ment, found to be equally as effective in the longer term
[8]. Central to achieving a beneficial alliance in this con-
text is clinician-patient communication. A link between
communication and patient adherence has been
observed extensively in general medicine. A recent meta
analysis synthesising results from correlational and ex-
perimental studies found the odds of a patient adhering
to be 2.16 times greater if their doctor is a good commu-
nicator [9]. Despite this, such reviews of communication
typically exclude studies of psychiatric patients [9,10].
‘Good’ communication is commonly expounded
through a ‘patient centred’ model in which principles of
patient involvement and collaboration are advocated
[47]. Collaborative communication and inclusion of the
patient’s perspective in relation to treatment decisions
specifically i.e. Shared decision making (SDM) has
emerged as a pivotal component in policy for mental
health [11]. Deemed ethically laudable and found to
yield improvements on outcomes in physical health [12],
both parties are encouraged to take steps to reach con-
sensus about treatment, engaging in patient-centric
communication that accounts for individual preferences.
This is based on the expectation that it will increase
self-determination and in turn patient treatment adher-
ence [13]. Little research has however systematically
examined the impact of SDM on outcomes in mental
health to affirm this [13,14]. Moreover, application of
such concepts is hampered by a lack of clear definition
and measurement, rendering the specific behaviours and
communication practices underlying patient centred
care and engagement unclear. No review to date has col-
lectively examined alliance and communication in men-
tal health in order to determine the aspects of each
phenomenon that mobilise adherence behaviours.This article presents an integration of evidence about
the empirical grounding for relationship variables, beha-
viors and messages instrumental to promoting engage-
ment with mental health treatment. The primary
objective was to identify whether an association exists
between clinician-patient alliance or communication and
treatment adherence in mental health care. Secondary
objectives were to locate specific aspects of the thera-
peutic encounter that may be harnessed to improve
treatment and describe the characteristics of literature.
Whilst alliance and communication are interlinked they
represent distinct phenomena. Alliance is a subjective
psychological construct held by participants on each an-
other and their interaction [15] e.g. bond, goals, rapport
or agreement [16]. Communication refers to compo-
nents of the behavioural exchange between clinician and
patient [15] with the potential to described either sub-
jectively and objectively e.g. information giving and
collaboration [17]. Associations with adherence are dif-
ferentiated in this review accordingly. The term alliance
is broadly used to represent the clinician-patient rela-
tionship. However, it may be construed elsewhere as the
‘therapeutic relationship’, ‘therapeutic alliance’, ‘helping al-
liance’ or ‘working alliance’ [18].
Methods
Search strategy
A rigorous journal screening was undertaken including all
electronically registered references up to December 2010.
An additional hand search in key journals of relevant
professional categories, grey literature and dissertations
was also performed. Table 1 denotes the sources used.
Table 2 depicts the terms used in the search process,
how they were combined and where truncation was used
in order to capture all relevant variants of the termin-
ology. Terms were categorised in four groups based on
the research question, representing synonyms or specifi-
cations of; ‘communication’ or ‘alliance’ (group 1) between
patients diagnosed with ‘mental disorder’ (group 2) and
‘professionals’ (group 3) and its impact on ‘adherence’
(group 4). In databases where limits were imposed on
search terms, the key terms i.e. communication/alliance
and adherence were used. The search process was aug-
mented by personal correspondence with experts, advis-
ing on appropriate terms and relevant literature.
Inclusion and exclusion criteria
Prior to the screening, strict inclusion criteria were spe-
cified to orient the search filtering process. For studies
to be deemed relevant, they included patient (or
professional-patient) samples where participants were
aged 18–65 and receiving treatment for psychotic disor-
ders, anxiety disorders or mood disorders. The search
was constrained to the main clinical disorders (Axis 1)
Table 1 Search resources
Databases Hand search Grey literature
Pubmed The British Journal of Psychiatry System for Information on Grey Literature (SIGLE)
PsycInfo The American Journal of Psychiatry British National Bibliography for Report Literature
Web of Science Schizophrenia Bulletin British Library Direct
Cochrane Library Archives of General Psychiatry Proquest Digital Dissertations
Embase Acta Psychiatrica Scandinavica
CINAHL. Journal of Psychiatric & Mental Health Nursing
Journal of Mental Health
Journal of Advanced Nursing
Issues in Mental Health Nursing
Journal of Psychosocial Nursing
Health and Social Care in the Community
British Journal of Occupational Therapy
Canadian Journal of Occupational Therapy
American Journal of Occupational Therapy
Journal of Occupational Science
British Journal of Social Work
Social Work in Mental Health
Journal of Social Work Practice.
Table 2 Search terms with truncation
Group terms combined by ‘AND’
combined by “OR” combined by “OR” combined by “OR” combined by “OR”
! group term 1 ! group term 2 ! group term 3 ! group term 4
Group 1 Group 2 Group 3 Group 4
communicat* psychosis psychiatr* adher*
talk psychotic Doctor complian*
interact* schizophr* mental health nurs* concordan*
expressed emotion schizoaffective psychiatric nurs* nonadher*
conversat* delusional social work* noncomplian*
discourse depress* psycholog* concordan*
dialogue dysthymi* care coordinator persistence
relationship bipolar counsel* treatment usage
alliance cyclothymi* therapist attendance
shared decision making panic support work* engag*
agoraphobia Psychosocial intervention work* rejection of therapy
phobia employment coach DNA
obsessive compulsive disorder nurse practitioner drop out
post traumatic stress disorder case manager medication possession ratio
stress vocational rehab specialist service use
anxiety psych tech
physician
provider
practitioner
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fessionals were defined as any clinician in contact with
this group within inpatient, community, primary care or
outpatient settings. Pertinent data was that which had
been collected via a subjective rating of the clinician-
patient alliance/interaction using a validated scale or
where a clear description of how the variable had been
measured was provided e.g. via a single item assessing
the state of the relationship [32]. Alternatively, an ob-
jective record and assessment of naturally occurring
communication was necessary (e.g. with ratings by inde-
pendent researchers of audio or video taped recording).
Also required, was an assessment of patient adherence,
via direct (e.g. pill count, blood test) or indirect (e.g. pa-
tient or clinician self-report) measures. ‘Adherence’ in
this review pertained to medication-taking behaviour
and/or appointment attendance. The resulting analysis
was considered appropriate if it, at minimum, assessed
the relationship (correlation) between alliance/commu-
nication and adherence, or tested for a significant differ-
ence between adherers and nonadherers in relation to
these variables. All included studies were in compliance
with the ethical principles of the Helsinki declaration
and approved by appropriate bodies.
Screening
Following searching, the resulting titles from each data-
base were screened in accordance with the research
aims. Potentially relevant abstracts were obtained for
further examination, a random selection of which (20%)
were screened independently by a secondary researcher
to check reliability and minimise potential bias. Full
texts of the selected abstracts were then retrieved for
more rigorous inspection and application of the exclu-
sion criteria. 6672 titles were found of which 6283
abstracts were considered irrelevant, leaving a total of
389 abstracts for screening after the removal of 31 dupli-
cates. Following further filtering, 114 full texts were
examined in their entirety of which 20 met the review’s
inclusion criteria. Whilst review articles were automatic-
ally excluded in the search, reference sections were in-
spected for potentially applicable citations. Three studies
were also retrieved from this additional search process.
Reasons for exclusion were recorded and discrepancies
discussed between independent researchers until con-
sensus was met. Figure 1 outlines the results of the
screening protocol using Quorum guidelines [20]. Only
studies fulfilling all inclusion criteria were reported in
the final review (n = 23).
Data extraction
Data extraction was conducted using an instrument
designed for this review to elicit all relevant aspects of
included articles. This allowed for both qualitative andquantitative accounting of the study including author,
title, year, country, treatment setting sample, aims, data
source, measures used, analysis, results, specific alliance/
communication variables associated with adherence, and
limitations of the study. Whilst numerous articles re-
ferred to general predictors of adherence, only outcomes
relating to alliance or communication were extracted.
Two reviewers independently recorded the data, consult-
ing with a third reviewer in the event of disparate docu-
mentation of study features.
Quality assessment
Quality assessment (QA) of the included studies was
problematic as there is no ‘gold standard’ design for
studies of clinician–patient alliance or interaction. A
review of QA for non-randomised trials demonstrated
six tools applicable to systematic reviews [60], from
which Down’s et al. (1998) [21] was selected as a
guide for its comprehensiveness. The studies were
assessed on four dimensions; reporting, external vali-
dity, internal validity and power. The tool required
adaptation to make it more applicable to the nature
of papers reviewed. For example, as the majority of
studies (n = 18) had no ‘interventions’, control groups
or blinding, questions pertaining to these issues were
removed. Instead, an additional QA variable was
added to assess the study design and it’s potential to
allow for causal hypotheses. Overall, study ratings for
each category were denoted as percentage score. The
QA criteria are outlined below.
1) Reporting: Do studies provide a clear description of
aims, outcomes, characteristics of patients, findings
and actual probability values? (Total/5).
2) External validity: Are those patients asked to
participate in the study were represented of the entire
population from which they were recruited? Patients
would be representative if they consisted of the entire
source population, an unselected sample of
consecutive patients, or a random sample (Total/1).
3) Internal validity: Are the statistical tests used to
measure the outcomes appropriate? Are both
adherence and alliance/communication measures
validated and reliable? Was there adequate
adjustment for confounding in the analyses from
which the findings were drawn? (Total/3).
4) Study design: To what extent can the study identify
causality? Scores differentiate between cross
sectional, prospective/longitudinal and experimental
designs (Total/2).
Overall Table 3 suggests a moderate quality of evi-
dence in this field. Of the 23 studies, 5 had low quality
scores (≤ 50%) 12 had moderate scores (>50%) and 6
Records identified through 
database searching 
(n = 6672 )
Additional records identified 
through other sources 
(n = 905) 
Records after duplicates removed
(n = 7546) 
Records screened
(n = 389 ) 
Records excluded
(n = 275 ) 
Full text articles 
assessed for eligibility 
(n =  114 ) 
Full text articles 
excluded, with reasons 
(n =  91 ) 
Studies included in 
qualitative synthesis 
(n = 23) 
Figure 1 Quorum diagram.
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mined threshold for high quality [21]. All studies exhib-
ited a strong standard of reporting and used appropriate
statistical tests. However, a number of collective limita-
tions can be identified. Validated measures were not
consistently implemented and external validity was low.
Often random sampling or consecutive admissions were
not used to recruit participants or detail was often insuf-
ficient to establish whether those who agreed to partici-
pate were representative of the entire source population.
All studies also incurred weak ratings in relation to
power due to a lack of formal sample size calculation.
Furthermore, identifying directionality of effect was
problematic in the majority of research reviewed. Most
studies adopted cross sectional designs and only four
studies examined the effect of communication on adher-
ence experimentally. The complexity of adherence deter-
minants are well documented, but studies inadequately
captured and discussed confounding in the analyses. For
example, most studies failed to capture and adjust for
side effects, consistently identified as one of the most
significant reasons for drug treatment failure across a
range of mental health disorders [4,43].
Analysis and findings
Criteria for conducting meta-analysis were not fulfilled
due to variability in the statistical procedures and mea-
sures used to analyse relationship, communication andadherence outcomes. The findings of the systematic re-
view are therefore synthesised below in accordance with
the original research questions. Seventeen studies
reported positive associations with adherence. Results
were considered positive if study authors reported a sta-
tistically significant (p< 0.05) association between adher-
ence and at least one relationship/communication
variable, or a statistically significant difference between
adherent and non-adherent patients on such measures.
The majority of studies focussed on patients diagnosed
with depression (n = 16). The remaining studies investi-
gated participants with a psychotic disorder (n = 8) or, least
frequently, bipolar disorder (n = 3). Literature was concep-
tualised as three categories on the basis that alliance and
communication may differentially influence adherence:
Group 1: global measures of clinician-patient alliance
(n = 10). Group 2: specific communication styles and/or or
messages communicated by the treating clinician (demon-
strated via subjective measures or experimental interven-
tions) (n = 6). Group 3: independently coded recordings
of naturally occurring clinical communication (n = 1).
Discussion of the studies and their pertinent results are
reported within the proceeding narrative synthesis.
Results
Clinician- patient alliance and treatment adherence
Alliance is consistently associated with adherence in
mental health. Of 10 studies (2 low quality, 7 moderate
Table 3 Quality assessment ratings for included studies
Paper Reporting External validity Internal validity Power Study design Study quality score %
Sajatovic et al. (2006) [22] 5/5 0/1 1/3 0/1 0/2 50%
Weiss et al. (2002) [23] 5/5 1/1 2/3 0/1 1/2 75%
Corriss et al. (1999) [24] 4/5 1/1 2/3 0/1 1/2 67%
Lecomte et al. (2008) [25] 5/5 0/1 2/3 0/1 0/2 58%
Startup et al. (2006) [26] 5/5 0/1 2/3 0/1 0/2 58%
Olfson et al. (2000) [27] 5/5 1/1 1/3 0/1 1/2 67%
Frank et al. (1990) [28] 5/5 0/1 2/3 0/1 1/2 67%
Zeber et al. (2008) [29] 5/5 0/1 2/3 0/1 0/2 58%
Perron et al. (2009) [30] 5/5 0/1 2/3 0/1 0/2 58%
Madsen et al. (2009) [31] 4/5 0/1 2/3 0/1 1/2 58%
Shigemura (2010) [32] 5/5 0/1 1/3 0/1 0/2 50%
Yeh et al. (2008) [33] 5/5 0/1 1/3 0/1 0/2 50%
Bull et al. (2011) [34] 5/5 0/1 1/3 0/1 0/2 50%
Lin et al. (1995) [35] 5/5 0/1 1/3 0/1 1/2 58%
Gonzalez et al. (2004) [36] 5/5 0/1 2/3 0/1 1/2 67%
Bultman et al. (2000) [17] 5/5 0/1 1/3 0/1 1/2 58%
Mahone et al. (2008) [37] 4/5 0/1 2/3 0/1 0/2 50%
Hamann et al. (2006 [14] 5/5 0/1 2/3 0/1 2/2 75%
Loh et al. (2007) [38] 5/5 0/1 2/3 0/1 2/2 75%
Loh et al. (2007) [39] 5/5 0/1 2/3 0/1 2/2 75%
Ludmen et al. (2003) [45]
Von Korff et al. (2003) [41] 5/5 0/1 2/3 0/1 2/2 75%
Sleath et al. (2003) [42] 5/5 0/1 2/3 0/1 1/2 67%
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some aspect of the clinician-patient relationship. Table 4
(See Additional File 1: Table S4) outlines the characteris-
tics and findings of all included papers. The clinician pa-
tient alliance was most frequently assessed via the
Working Alliance Inventory (WAI) [16] (n = 4). This in-
strument, used in patient/clinician self-report or obser-
ver rated versions, provides measures of three related
components hypothesised to determine the degree and
quality of clinician helping alliances: a) patient and ther-
apist agreement on the goals of treatment, b) patient
and therapist agreement on the tasks to achieve these
goals and c) the development of a personal bond be-
tween patient and therapist. Whilst two studies found
no positive associations when analysing these factors
globally [22,25], one study combining cross sectional
and longitudinal prospective analyses found adherence
difficulties not only to be associated with weaker working
alliance, but demonstrated its impact on the time-course
of adherence maintenance in initially adherent patients
and the development of adherence in initially nonadher-
ent patients [23].
A particularly important aspect of the working alliance
may be patient-clinician agreement on the tasks oftreatment, found by two studies to be significantly as-
sociated with patient adherence in subscale analyses
[24,26]. In a psychotherapy (Cognitive Behaviour Ther-
apy) setting, therapist and patient agreement on the
goals of treatment was also relevant to premature ter-
mination of therapy [26]. However, arguably this finding
may be due to the formulaic nature of the therapy where
clearly defined goals are inherent to the process. Main-
stream psychiatric services differ from conventional
psychotherapy in important respects including the
commonly open-ended nature of treatment, actual or
potential use of coercive treatment measures and higher
variability of the frequency, length and goals of consulta-
tions [15]. In attempt to address this issue the same
study used a dual measure of adherence, the Active En-
gagement Scale, a 15-item questionnaire, assessing pri-
marily involvement in therapy and collaborative
participation. Three studies [26-28] found significant
associations with this definition of alliance. As prospect-
ively observed over a two year period, the more actively
engaged in therapy patients become the more likely they
may be to take their medication as prescribed [28].
Moreover, particularly crucial dimensions of active en-
gagement for adherence may be patient optimism about
Thompson and McCabe BMC Psychiatry 2012, 12:87 Page 7 of 12
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therapy, patient interest in understanding their illness
and realistic perceptions of the therapist [27].
The ‘alliance’ has also been extended beyond the pri-
mary treating clinician and patient to encompass entire
mental health teams. Two studies [29,30] solicited per-
ceptions of the therapeutic alliance using The Health
Care Climate Questionnaire (HCCQ) [40]. This 10-item
bipolar disorder-specific instrument, elicits the degree of
comfort a patient expresses with their treatment accord-
ing to statements regarding their care environment as it
has been developed by their mental health team. For ex-
ample, ‘I feel encouraged by my mental health team’ and
‘I am encouraged to ask questions about my treatment’.
One study analysing the overall HCCQ rating found a
significant association with the baseline measure of alli-
ance but not 1 year follow up [30]. This suggests that
provider team support may contribute to client motiv-
ation and engagement. However, the causal associations
are unclear. In the second study, adherence outcome
was differentiated by missed doses and interpersonal
barriers to adherence. The Overall HCCQ score was sig-
nificantly associated with interpersonal barriers to adher-
ence but not missed medication doses. Similarly, in
individual item analyses, certain alliance variables were
associated differentially to the two dimensions of adher-
ence measured. Salient aspects of team alliance related
to both measures were identified as conveying confi-
dence in the patients ability to make changes, ensuring
the patient and team stay in frequent contact and regu-
larly reviewing the patient’s progress in managing all
aspects of their treatment plan. Finally, in a significantly
larger sample, an internet-based survey among 1151
patients with major depressive disorder found low ad-
herence was associated with, and predicted by, a neutral
or negative doctor-patient relationship [32].
Communication styles and clinical messages related to
adherence
Other studies have employed greater specificity in cap-
turing aspects of the clinician-patient interaction. This
enables identification of candidate communication styles
and clinical messages that may mobilise adherence. Of
12 studies (3 low quality, 4 moderate and 5 high), eight
found at least one or more variable to be postively asso-
ciated. So how should clinicians co-act with patients to
optimise the therapeutic encounter? The extent to which
patients perceive behavioural traits such as listening,
empathy and respectfulness to manifest in the clinician’s
communication style relates to their following of medi-
cation directions [33]. However, the practitioner’s ability
to elicit patient’s perspective about treatment may be
specifically important. Patients who identify a participa-
tory decision making style in clinicians, their propensityto involve them in treatment decisions, have been found
to be more adherent at 6 months follow up [36] and 6–
8 weeks post initial consultation [38]. Imparting infor-
mation within such an approach, including facts about
the disease and treatment, may also be factorial in ad-
herence behaviours [38]. Evidence for SDM is however
inconsistent. In another sample, the degree to which
outpatients viewed their prescribing doctor as exhibiting
a collaborative style in relation to similar items was not
associated with subsequent adherence at 3, 6, 9 or
12 weeks [31]. Whilst an explanatory hypothesis for
contradictory findings could be variation in patient pre-
ference for decision involvement, a further study found
no association between perceived participation and ad-
herence, even when the degree of patient involvement
was aligned with their preference for SDM [37].
These studies examined subjective perceptions of
SDM. However, the construct has also been explored ex-
perimentally with similarly inconsistent findings. Three
trials explored the impact of a multi faceted interven-
tion. The first applied a decision aid, a 16 page booklet
addressing the pros and cons of alternative types of anti-
psychotic medication, and a planning talk between pa-
tient and physician to establish agreement on further
treatment [44] In the second, physicians were trained in
SDM and a decision board for use during encounters
was distributed to the patients, in addition to evidence
based information about depression care and specific en-
couragement for patients to be active in the decision
making process [39]. Though such tools are designed to
enhance patient involvement, both studies found no ef-
fect on adherence compared to routine care. In the third
sample however, clinicians were trained to provide a
complex intervention involving an SDM element. Inter-
vention patients received an educational book, videotape
about effective management of chronic or recurrent de-
pression, in-person visits and telephone monitoring and
were significantly more likely to refill antidepressant
medication prescriptions than usual care patients during
the one year follow up period [41,45].
If indeed collaborative communication stimulates ad-
herence behaviours, its positive influence may be attrib-
utable to an intervening variable i.e. enhancing patient
beliefs about the medication prescribed [17]. One unique
study tested a theoretical model suggesting that phys-
ician (initial and follow up) collaboration style influences
client medication beliefs and in turn medication-taking
behaviour. Fundamental elements of physician initial
communication style, derived form the Health Commu-
nication Model [46] included the degree of friendliness
during the visit, asking if the patient had questions or
concerns, assisting with issues relating to the use of
medication, providing clear instructions on how to take
medication, clearly explaining how the antidepressant
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patient can take to feel better. Key components of the
follow up communication style were considered to be
the extent to which the physician encourages expression
of concerns or problems with taking medication, asks
about and listens to concerns about medication and
helps solve problems related to the patient’s use of medi-
cation. This study highlights the importance of collab-
orative communication about treatment specifics more
generally rather than specifically treatment decisions.
Consistent with this, two studies [34,35] identified dis-
tinct medication-related messages that may have a bear-
ing on adherence behaviour. That is, the time period
patients are instructed to take their medication and dis-
cussion regarding side effects may be instrumental in de-
creasing the odds of discontinuing antidepressant
therapy. Patients told to take their medication for longer
were found to be less likely to adhere to their medica-
tion. Furthermore, communication regarding adverse
effects may significantly decrease the odds of terminat-
ing antidepressant therapy [34].
Potential medication-related motivators of adherence
in the initial phase of antidepressant treatment have also
been identified [35]. These include physician question
asking about prior use of antidepressants, instructions
provided by the doctor i.e. to continue medication use
even when symptoms have alleviated; check before dis-
continuing medication; take medication daily, and advis-
ing the patient what to do in case of questions. General
discussion of pleasant activities may also be important
to initial motivation to adhere to regimens. In this study,
no communication variables were found to be significant
predictors of later stage adherence, suggesting important
topics are be dependent on the stage of treatment. An-
other study assessing the same communication messages
did not find them to be related to antidepressant adher-
ence [36].
Objectively measured communication and adherence
Communication signifies an observable behavioural ex-
change between the patient and clinician and therefore
has the potential to be captured in objective terms by an
independent observer [15]. Despite this, only one study
(of moderate quality) examined the relationship to ad-
herence via this method [42]. Analysis was performed
on a data set including 27 resident physicians who were
each audio taped with 6 to 21 of their Spanish or English
speaking patients within general internal medicine or
family practice. Researchers coded specific communica-
tion variables from transcripts including 1) discussion of
antidepressants during the encounter 2) number of dif-
ferent types of information the doctor provided the
patients about antidepressants 3) number of physician
questions about antidepressants 4) number of differenttypes of information the patient stated regarding antide-
pressants 5) number of questions the patient asked
about antidepressants. Adherence was assessed for the
100-day period after the audio taped consultation via
pharmacy prescription refill records. Analyses determin-
ing how the communication variables were related to
adherence, demonstrated that only patient question ask-
ing was significant. That is, patients who asked more
questions regarding their medication during the encoun-
ter were less adherent to their therapy during the 100-
day period after their visit. However the fact that
medication-specific discussion was not found to be asso-
ciated with adherence is in contrast to the previous re-
search reviewed.
Variability in adherence measures
The variability in assessment and definition of adherence,
as evident in Table 4, presents an important consideration
as comparability between studies is affected. Most fre-
quently, adherence was assessed via patient report (n=14),
consistent with an identified preference for this method in
mental health [48]. Choice of measures and criteria for
non adherence however were heterogeneous, ranging from
patients being asked if they had stopped taking their medi-
cation for a period of one week or more during the inter-
mittent follow up period [27], to patient’s rating on a scale
of 0–100 how often they forgot to take their medication,
alter their dose, or miss a dose intentionally to suit their
needs. The only measure to be duplicated between studies
[29,30] was the Morisky scale [49]. Three studies used a
combination of therapist and patient reports [28,39,44]
and two studies [23,24] used solely therapist report, both
of which employed a 4-point likert scale with ratings from
1 ‘active compliance’ to 5 ‘passive compliance’ [50]. Direct,
i.e. objective, assessments were only used in four studies
[26,36,42,44] in the form of pharmacy refill records, pre-
mature termination of therapy and blood plasma levels.
Subjective measures were therefore predominantly adopted
which, particularly when used in isolation, can be suscep-
tible to bias. For example, exaggerating the degree of ad-
herence (patient self-report) and basing adherence
judgements on deteriorating clinical state or inaccurate
perception of agreement about treatment [51] (therapist-
report). In line with existing literature [48], this review
highlights the opportunity for advancement in adherence
research. Most notably in relation to consensus develop-
ment, allowing for studies to be compared on a common
variable. In turn, more valid conclusions could be drawn
when assessing the effect of alliance or communication.
Discussion
Summary of main results
To our knowledge, this is the first review to examine al-
liance, communication and adherence in mental health.
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http://www.biomedcentral.com/1471-244X/12/87Twenty-three articles met the inclusion criteria. The
methodological quality overall was moderate, reflecting
largely cross-sectional nature of the research in this field
and limitations in comparability and identifying causality.
Ten papers examined the relationship between adherence
and the clinician-patient alliance, which emerged as a con-
sistent predictor, though its components have differential
significance. Twelve studies examined specific communi-
cative styles or messages, only four of which employed
intervention designs. Shared decision making yields incon-
sistent results in relation to patient engagement. However,
collaborative features of communication more generally,
such as imparting medication-related information and dis-
cussing the practicalities of treatment specifics, were posi-
tively associated, though less studied. Only one study
explored the association between adherence and observer
rated clinical communication, highlighting a gap in psy-
chiatric literature for more objective methods of commu-
nication measurement. Specific mechanisms related to
treatment engagement are discussed in more detail.
Specific communication mechanisms that result in patient
engagement
It is commonplace to conceptualise the clinician-patient
relationship as one depending on ‘bond’ and rapport
[52,53]. This review shows that in relation to adherence,
more task-oriented elements of the alliance may be in-
strumental. Agreement on the tasks of treatment, collab-
orative participation and regularity of contact with
clinicians for example emerge as ‘active’ elements of the
alliance. The treatment context may however influence
the magnitude of benefit from these factors e.g. Goal
elements in a psychotherapy setting [26] may preside
over such task-based features relative to an outpatients
setting [22]. It is unclear how a positive clinician-patient
alliance translates to specific communication styles and
messages that can be utilised to improve engagement.
This is attributable to less consistent findings in the field
of communication research and a lack of observed nat-
urally occurring clinical communication. However, this
review presents two main candidates for clinicians to
consider. SDM provides a model of communication to
enhance patient involvement in the decision process of
consultations, but is inconsistently associated with ad-
herence in mental health. Whilst associated tools such
as decision aids help patients make deliberative choices
among treatment options and a provide a platform from
which they can assess risks and benefits, non-significant
associations with adherence outnumber positive. This
uncertainty is further complicated by difficulties in
examining effects of complex interventions with SDM
elements. For example, arguably the positive outcomes
in Ludmen/Von Korff et al. [41,45] cannot be ascribed
solely to the SDM element as it was part of a multi-faceted intervention. Sharing preferences about treat-
ment may be particularly challenging in mental health
care due to the nature of symptoms that make establish-
ing a shared understanding about treatment problematic.
Research must identify the complications of sharing
decisions in these contexts to further understand the re-
lationship with adherence behaviours.
Despite this, collaborative communication throughout
the consultation more generally appears vital. Clinicians
who are friendly, explain medication, address questions
and concerns and discuss treatment specifics e.g. medi-
cation instructions, are more likely to have patients who
adhere to regimens. Though further pathway research is
necessary to reinforce findings [54], the mechanism by
which this occurs may be enhancement of patient beliefs
about medication. The emphasis on medication-specific
discussion certainly aligns with the notion that know-
ledge maybe an important patient factor clinicians can
influence in order to improve adherence in mental
health. Patients need to be informed about and compre-
hend treatment. Coupled with the finding that clinician
optimism is associated with adherence, perhaps provider
attitudes towards treatment, manifest in communication,
can influence patient’s expectations of prescribed treat-
ment. Indeed, when studied outside of the context com-
munication, clinician attitudes towards medications have
been found to impact patient’s medication adherence in
mental health [55].
Only one study was able to objectively identify a spe-
cific communication practice, patient question asking, as
related to adherence. Given the finding that communica-
tion may mediate beliefs and knowledge about medica-
tion [17], perhaps more question asking reflects less
understanding on the part of the patient. Further studies
of this nature may enable identification of specific prac-
tices that either indicate patients risk of nonadherence,
or are involved in mobilising self care behaviours in
mental health. This review has demonstrated a clear
paucity of objectively measured natural clinical com-
munication in mental health.
Comparison to literature
The findings of this review are consistent with mental
health research identifying the alliance to be associated
with other treatment outcomes [56]. An emphasis on
agreement about tasks of treatment is in line with per-
ceived patient agreement being associated with adher-
ence in general medicine [51]. It has been suggested that
discussing treatment specifics, highlighted in this review,
enhances clinician’s ability to perceive such patient agree-
ment [51]. The potential for perceived collaboration in
clinical encounters to encourage patient engagement
aligns with findings in general medicine that collabor-
ation is associated with improved adherence [57].
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ment decisions specifically i.e. SDM is inconsistent with
more positive outcomes in general medicine [12], but
consistent with reviews in mental health examining SDM
and a range of patient outcomes [13]. Interestingly, un-
like general medicine where numerous empirical studies
from various populations and settings link systematically
coded communication to adherence [9], only one study
objectively measured naturally occurring clinical interac-
tions, suggesting a research deficit in psychiatry
specfically.
Limitations
Whilst informative, the review should be considered
within the context of its limitations. No meta-analysis
was conducted due to the heterogeneity of methods.
Estimates of overall effects could not therefore be calcu-
lated. It also remains possible that studies in this field
are susceptible to publication bias hence the frequency
of positive associations relative to negative ones may be
overstated. Furthermore, papers in mental health were
examined collectively rather than differentiated by dis-
order. Arguably, this distinction could be important if
settings i.e. inpatient/outpatient or diagnostic groups
have different communicative needs. Clinician-patient
alliance and communication in schizophrenia for ex-
ample, addressed in 7 studies, is complicated by the na-
ture of psychotic symptoms [58].
Implications of findings for future research
This review underlines methodological weaknesses that
may be useful to address in future research. Only six
studies were deemed high quality according to QA cri-
teria. Whilst practical constraints of cross-sectional
studies in naturalistic settings are expected, general
improvements to derive from these findings relate to;
increasing implementation of validated measures and
supplying adequate information on reliability and in-
ternal consistency; striving for larger sample sizes and
performing formal sample size calculations to increase
precision in extrapolating effects to the wider mental
health care population; employing random sampling or
recruiting consecutive patient admissions to optimise ex-
ternal validity and the potential inferences that can be
made.
Beyond this, five areas may offer particularly salient
improvements to research in this field; Firstly, whilst alli-
ance was mostly assessed via validated instruments, the
dimensions of this construct varied between measures. It
may be important to distinguish between components in
analyses and explore their differential associations with
adherence, e.g. clinician-patient agreement about the
tasks of treatment may be more important than bond, in
order to enhance the potential application of findings inclinical practice and training. This may be possible by
performing subscale analyses of measures in addition to
global ratings.
Secondly, whilst alliance and communication are inter-
related, they are analytically distinct concepts. It is there-
fore difficult to consider how specific communication
practices are involved in the formation of a positive alli-
ance. Furthermore, generalised communication coding
categories such as ‘discussions about medication’ may
fail to account for the wide range of behaviors and con-
tent these interactional events may incorporate. Invest-
ing more effort, and specificity, in studying clinical
communication variables may provide a fruitful starting
point from which we can look at how, and if, such prac-
tices are related to subjective perceptions of alliance and
outcomes like adherence. More objective micro analytic
methods such as conversation analysis that account for
context, sense making and clinician-patient interactivity
may be useful approaches in achieving this.
Thirdly, whilst it is appealing to conclude that alliance
and communication have an impact on patient cooper-
ation with treatment regimens, it is important to con-
textualise any effect within the interplay of other
possible adherence determinants e.g. illness related,
demographic and psychosocial factors. These potential
confounders should be sufficiently adjusted for in future
research so valid inferences about the effect of the clin-
ical interaction can be made.
Fourthly, longitudinal prospective studies that follow
patients and clinical interactions over time are necessary
to account for the potentially dynamic nature of adher-
ence behavior and that the clinician-patient alliance may
change or develop. To increase comparability between
studies it may be useful for each investigation to report
a mean percentage of medication consumed throughout
the follow up period, even if the primary measure of ad-
herence is operationalised otherwise [48].
Finally, due to the largely correlational nature of re-
search reviewed, the directionality of effect can only be
speculated upon. The question of whether the predictive
power of the alliance or communication derives from
the effect of patient engagement itself on the interaction,
or even patient characteristics present at the start of
treatment, remains pertinent in future research. Fur-
ther experimental studies or use of causal modelling
techniques would allow researchers to elicit directions
of causality and eliminate the alternative explanation
that a strong alliance is not a pre-requisite for better
adherence, but rather a consequence of positive clinical
change.
Conclusions
Adherence to mental heath treatment is frequently a
challenge for practicing clinicians. Treatment and patient
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search. However, this review shows providers play a role
in mitigating nonadherence. A positive alliance is asso-
ciated with more favorable adherence. How this translates
into tangible communication practices, and the mechan-
isms by which these may influence treatment engagement
are less conclusive and require more sophisticated studies
and methodological techniques. Communication repre-
sents an observable exchange between patient and clin-
ician that may be objectively described. However,
adherence research relies mainly on subjective measures,
making actual communication relatively under researched
in mental health compared to medicine more widely.
Addressing this deficit, and the considerable methodo-
logical limitations in this field, could facilitate better appli-
cation of findings in clinical practice. Currently, literature
implies providers should engage patients collaboratively
in the consultation in order to establish agreement sur-
rounding the tasks of treatment, an important aspect of
alliance. Training clinicians to discuss treatment specifics,
including patient concerns about treatment may improve
their ability to perceive this agreement [51]; improve
patient’s beliefs about and attitudes towards treatment;
and gain insight into the idiosyncratic reasons outside of
the clinical interaction also underling nonadherence. As
such, whilst time constraints on psychiatric encounters
pose a challenge to clinicians in developing bonds with
patients, more effective collaboration on practical
aspects of treatment may be one way of compensating
for this. Clinicians should also observe features of pa-
tient communication e.g. question asking that maybe in-
dicative of engagement both within, and external to, the
consultation. SDM is outlined in policy as a preferred
mode of communication that will improve patient adher-
ence. However, further research is necessary to under-
stand this relationship. Arguably, the implementation of
such patient-centred principles may be particularly chal-
lenging in psychiatry [59]. Despite methodological defi-
ciencies in this field, engagement in the psychiatric
consultation itself may impact patient engagement with
treatment more globally.
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